This Week in Nature | GenomeWeb

This Week in Nature

In this week's Nature Biotechnology, a team from Massachusetts General Hospital reports on the development of a next-generation CRISPR-based gene-editing platform. Monomeric Cas9 nucleases are commonly used to induce the genomic alterations in CRISPR systems, but the researchers note that these often result in unwanted off-target mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Cell

This Week in Nature

This Week in PLOS

Nobel Gazing

This Week in Nature

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.